For Benefit Medicines (FBM) is Australia's first for-purpose pharmaceutical enterprise, founded in 2015. FBM commercializes generic prescription medications for oncology and specialty health conditions in the Australian PBS system. 100% of net profits from pharmaceutical sales are distributed to patient support and health research charities (such as Breast Cancer Trials and the Leukaemia Foundation), having contributed over $1 million to Australian medical research.



Registered Business Identity
Legal Entity Name
For Benefit Medicines Pty Ltd
Business Registered In
Australia
Registration Number
ACN 608 043 277 / ABN 87 608 043 277
Official Websites
Corporate Pathway: Pathway 3: The 100% Profit-Donation Model [Expand]
For Benefit Medicines operates under a legally binding constitution committing 100% of company net profits to Australian medical research and patient advocacy charities.
Read more about the different Profit 4 Good Pathways →Goods & Services
Pharmaceutical PBS Medicines & Healthcare Supply: High-quality, TGA-approved generic medications.
- Oncology and Cancer Therapies Listed on the Pharmaceutical Benefits Scheme (PBS)
- Specialty Generic Medications for Hospital and Community Pharmacies
Profit Distribution Method
100% Pharmaceutical Profit Distribution: All net commercial margins flow to clinical trials and cancer research organizations in Australia.
Ethical Accountability & Governance
Charitable Purposes
- Funding pioneering cancer research and clinical trials in Australia
- Lowering healthcare costs through affordable generic medication supply
The Charitable Ownership Advantage (COA)
This business operates under a strict lock-box corporate structure. By constitution or trust deed, 100% of net profits generated are locked and diverted directly to global development and philanthropic initiatives. At price parity, daily trade funds extreme poverty reduction.

